{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:55:42Z","timestamp":1774544142216,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>BK virus-associated nephropathy (PvAN) increases the risk of graft failure justifying treatment. Conversion to mammalian target of rapamycin inhibitors (mTORi) and Human polyclonal immunoglobulins (IVIg) could prevent the risk of PvAN. Our retrospective study assessed the efficacy of mTORi associated with IVIg therapy (mTORi\u00b1IVIg group) versus standard immunosuppression reduction to clear BKV DNAemia. Among forty-three kidney-transplanted patients with positive BKV DNAemia, we included twenty-six patients in the mTORi\u00b1IVIg group and reduced immunosuppression therapy for seventeen patients. We focused on BKV DNAemia clearance on the first-year. Renal function, rejection rate, evolution to PvAN, and complications of immunosuppression were assessed. BKV DNAemia decreased faster and significantly in the control group as compared to the mTORi\u00b1IVIg group (p &lt; 0.001). Viral clearance was significantly higher in the control group compared to the mTORi\u00b1IVIg group (88% vs. 58%; p = 0.033). Death-censored graft loss, rejection rates and kidney-graft function at 12 months did not significantly differ. Multivariate analyses significantly associated BKV DNAemia clearance with reducing immunosuppression (OR = 0.11 (0.06\u20130.9), p = 0.045), female kidney donor (OR = 0.10 (0.01\u20130.59\/)], p = 0.018) and time to first DNAemia, (OR = 0.88 (0.76\u20130.96), p = 0.019). In our study, the standard treatment for BKV DNAemia had better outcomes than an mTORi\u00b1IVIg conversion.<\/jats:p>","DOI":"10.3390\/jcm11247292","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T03:23:49Z","timestamp":1670556229000},"page":"7292","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study"],"prefix":"10.3390","volume":"11","author":[{"given":"Carla","family":"Vela","sequence":"first","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-7506","authenticated-orcid":false,"given":"Thomas","family":"Jouve","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"},{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloi","family":"Chevallier","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farida","family":"Imerzoukene","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-5930","authenticated-orcid":false,"given":"Rapha\u00eble","family":"Germi","sequence":"additional","affiliation":[{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"},{"name":"Virology Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Le Marechal","sequence":"additional","affiliation":[{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"},{"name":"Infectious Disease Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7991-1733","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Truffot","sequence":"additional","affiliation":[{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"},{"name":"Virology Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3049-5318","authenticated-orcid":false,"given":"Ga\u00eblle","family":"Fiard","sequence":"additional","affiliation":[{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"},{"name":"Urology Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Janbon","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Giovannini","sequence":"additional","affiliation":[{"name":"Pathology Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Malvezzi","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5130-7286","authenticated-orcid":false,"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"},{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-0392","authenticated-orcid":false,"given":"Johan","family":"Noble","sequence":"additional","affiliation":[{"name":"Nephrology, Hemodialysis, Apheresis and Kidney Transplantation Department, Universitary Hospital Grenoble, 38000 Grenoble, France"},{"name":"Medicine Faculty, University of Grenoble Alpes, 38000 Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive Drugs for Kidney Transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","article-title":"New human papovavirus (B.K.) isolated from urine after renal transplantation","volume":"297","author":"Gardner","year":"1970","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-92-3-373","article-title":"Human polyomavirus infections with JC virus and BK virus in renal transplant patients","volume":"92","author":"Hogan","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Funahashi, Y. (2021). Bk virus-associated nephropathy after renal transplantation. Pathogens, 10.","DOI":"10.3390\/pathogens10020150"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-6143.2002.020106.x","article-title":"Polyomavirus BK Nephropathy: A (Re-) emerging Complication in Renal Transplantation","volume":"2","author":"Hirsch","year":"2002","journal-title":"Am. J. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation\u2014Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3904\/kjim.2015.30.6.865","article-title":"Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients","volume":"30","author":"Lee","year":"2015","journal-title":"Korean J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of Polyomavirus Infection in Kidney Transplant Recipients: A Systematic Review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Shen, C.L., Wu, B.S., Lien, T.J., Yang, A.H., and Yang, C.Y. (2021). Bk polyomavirus nephropathy in kidney transplantation: Balancing rejection and infection. Viruses, 13.","DOI":"10.3390\/v13030487"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e132163","DOI":"10.1111\/ctr.13216","article-title":"Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection?","volume":"32","author":"Parajuli","year":"2018","journal-title":"Clin. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am. J. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15171\/jnp.2016.01","article-title":"Place of mTOR inhibitors in management of BKV infection after kidney transplantation","volume":"5","author":"Jouve","year":"2015","journal-title":"J. Nephropathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.transproceed.2017.06.030","article-title":"Mycophenolate Mofetil Withdrawal with Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients","volume":"49","author":"Wojciechowski","year":"2017","journal-title":"Transplant. Proc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/TP.0b013e3181daaaf1","article-title":"Polyomavirus bk neutralizing activity in human immunoglobulin preparations","volume":"89","author":"Randhawa","year":"2010","journal-title":"Transplantation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e00393-19","DOI":"10.1128\/AAC.00393-19","article-title":"Intravenous immunoglobulin administration significantly increases BKPyV genotype-specific neutralizing antibody titers in kidney transplant recipients","volume":"63","author":"Velay","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1399-3046.2010.01384.x","article-title":"Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients","volume":"16","author":"Anyaegbu","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.transproceed.2018.01.021","article-title":"High-Dose Intravenous Immunoglobulin Treatment of Polyomavirus Nephropathy Developing After T Cell\u2013Mediated Rejection Treatment: A Case Report","volume":"50","author":"Hwang","year":"2018","journal-title":"Transplant. Proc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation","volume":"16","author":"Matsumura","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e13300","DOI":"10.1111\/tid.13300","article-title":"Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients","volume":"22","author":"Moon","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients\u2014Results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: Long-term outcomes","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-3062.2006.00167.x","article-title":"Polyomavirus-associated nephropathy: Update on BK virus-specific immunity","volume":"8","author":"Comoli","year":"2006","journal-title":"Transpl. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/TP.0b013e3181bca422","article-title":"Inhibition of Polyomavirus BK-Specific T-Cell Responses by Immunosuppressive Drugs","volume":"88","author":"Egli","year":"2009","journal-title":"Transplantation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ki.2015.215","article-title":"A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients","volume":"88","author":"Weist","year":"2015","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T cell differentiation","volume":"460","author":"Araki","year":"2010","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN Analysis of National Registry Data on Treatment of BK Virus Allograft Nephropathy in the United States","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2215\/CJN.13221216","article-title":"CMV and BKPyV infections in renal transplant recipients receiving an mtor inhibitor\u2013based regimen versus a cni-based regimen: A systematic review and meta-analysis of randomized, controlled trials","volume":"12","author":"Mallat","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3062.2011.00649.x","article-title":"Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients","volume":"13","author":"Calvo","year":"2011","journal-title":"Transpl. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-3046.2008.00958.x","article-title":"Intravenous immunoglobulin as rescue therapy for BK virus nephropathy","volume":"13","author":"Sharma","year":"2009","journal-title":"Pediatr. Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK Virus Nephropathy by Combination Antiviral Therapy with Intravenous","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant. Direct"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/tri.12616","article-title":"ABO desensitization affects cellular immunity and infection control after renal transplantation","volume":"28","author":"Schachtner","year":"2015","journal-title":"Transpl. Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/24\/7292\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:36:36Z","timestamp":1760146596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/24\/7292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":37,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["jcm11247292"],"URL":"https:\/\/doi.org\/10.3390\/jcm11247292","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}